Back to Journals » International Journal of General Medicine » Volume 6

Intrapleural hemorrhage due to alteplase use in a 6-year-old boy with pleural effusion

Authors Hendaus MA, Abushahin A

Received 7 February 2013

Accepted for publication 28 February 2013

Published 12 April 2013 Volume 2013:6 Pages 233—236

DOI https://doi.org/10.2147/IJGM.S43783

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 6


Mohamed A Hendaus, Ahmad Abushahin

Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar

Background: Intrapleural fibrinolytics have been used successfully worldwide for the management of complicated pleural effusions and empyema. Bleeding complications are usually mentioned as rare side effects, but there is no clear information in the literature addressing the alarming outcome that might result following the use of alteplase as a fibrinolytic in the management of complicated parapneumonic effusions. We present a rare, if not unique, case of intrapleural hemorrhage requiring transfusion after alteplase use as a fibrinolytic in a 6-year-old male with complicated parapneumonic effusion.
Methods: A search of the PubMed database was carried out, using a combination of the following terms: alteplase, fibrinolytic, intrapleural hemorrhage, and side effects.
Results: The majority of studies found in the search concentrated on the efficacy of intrapleural fibrinolytics in the management of pleural effusion, but very few of the reports addressed the bleeding complications which may be caused by the treatment.
Conclusion: Although intrapleural and systemic hemorrhage are rare side effects of intrapleural fibrinolytic use, the health care provider must be watchful for these potentially life-threatening complications. Further studies are needed to understand not only the efficacy of fibrinolytics but also their safety, especially in children.

Keywords: alteplase, tPA, fibrinolytic, intrapleural hemorrhage, pleural effusion

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]